BR112012004080A2 - composições farmacêuticas para tratar ibd - Google Patents

composições farmacêuticas para tratar ibd

Info

Publication number
BR112012004080A2
BR112012004080A2 BR112012004080A BR112012004080A BR112012004080A2 BR 112012004080 A2 BR112012004080 A2 BR 112012004080A2 BR 112012004080 A BR112012004080 A BR 112012004080A BR 112012004080 A BR112012004080 A BR 112012004080A BR 112012004080 A2 BR112012004080 A2 BR 112012004080A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
treating ibd
ibd
treating
pharmaceutical
Prior art date
Application number
BR112012004080A
Other languages
English (en)
Inventor
Hans Schram
Laura Buttafoco
Michael Ikechukwu Ugwoke
Original Assignee
Disphar Internat Bv
Nordic Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Disphar Internat Bv, Nordic Pharma filed Critical Disphar Internat Bv
Publication of BR112012004080A2 publication Critical patent/BR112012004080A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
BR112012004080A 2009-08-26 2010-08-25 composições farmacêuticas para tratar ibd BR112012004080A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09290645A EP2298321A1 (en) 2009-08-26 2009-08-26 Novel pharmaceutical compositions for treating IBD
PCT/IB2010/053812 WO2011024122A1 (en) 2009-08-26 2010-08-25 Pharmaceutical compositions for treating ibd

Publications (1)

Publication Number Publication Date
BR112012004080A2 true BR112012004080A2 (pt) 2016-03-08

Family

ID=41491565

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012004080A BR112012004080A2 (pt) 2009-08-26 2010-08-25 composições farmacêuticas para tratar ibd

Country Status (9)

Country Link
US (1) US9511019B2 (pt)
EP (2) EP2298321A1 (pt)
JP (1) JP5693581B2 (pt)
CN (1) CN102573852A (pt)
AU (1) AU2010288203B2 (pt)
BR (1) BR112012004080A2 (pt)
CA (1) CA2771871C (pt)
RU (1) RU2561040C2 (pt)
WO (1) WO2011024122A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
ATE251449T1 (de) 1999-06-14 2003-10-15 Cosmo Spa Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
EP2396082B1 (en) 2009-02-16 2013-07-31 Nogra Pharma Limited Methods for treating hair related conditions
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
RU2616500C2 (ru) 2011-10-31 2017-04-17 Новартис Аг Композиция пазопаниба
EA030762B1 (ru) 2012-02-09 2018-09-28 Ногра Фарма Лимитед Способы лечения фиброза
CA2864065A1 (en) * 2012-02-13 2013-08-22 Cosmo Technologies Limited Method for treating intestinal diseases presenting at least one inflammatory component
US9682050B2 (en) 2012-04-18 2017-06-20 Nogra Pharma Limited Methods of treating lactose intolerance
US20170000727A1 (en) * 2013-12-20 2017-01-05 Disphar International B.V. Dry enema product
WO2017046343A1 (en) * 2015-09-17 2017-03-23 Nogra Pharma Limited Compositions for rectal administration in the treatment of ulcerative colitis and methods of using same
KR20210125047A (ko) 2019-02-08 2021-10-15 노그라 파마 리미티드 3-(4'-아미노페닐)-2-메톡시프로피온산, 및 그의 유사체 및 중간체의 제조 방법
RU2752082C1 (ru) * 2020-09-29 2021-07-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство с гранулами, содержащими 5-аминосалициловую кислоту и фолиевую кислоту, с контролируемым высвобождением

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3134718A (en) 1963-12-12 1964-05-26 Schering Corp Pregna-1,4-dienes and compositions containing same
US5498608A (en) 1994-01-07 1996-03-12 Salix Pharmaceuticals Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
DE19849737A1 (de) * 1998-10-28 2000-05-04 Falk Pharma Gmbh Kombinationsmittel zur Behandlung entzündlicher Darmerkrankungen
JP2004534841A (ja) * 2001-07-09 2004-11-18 コンビナトアールエックス インコーポレーティッド 炎症疾患の治療のための組合せ
GB0203421D0 (en) 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
CA2491355A1 (en) * 2002-07-05 2004-01-15 Temrel Limited Controlled release compositions comprising coated pellets having non-uniform coating thicknesses
GB0329851D0 (en) * 2003-12-23 2004-01-28 Temrel Inc Process for producing particles for pharmaceutical compositions
EP1810666A1 (en) * 2006-01-19 2007-07-25 Ferring International Center S.A. Foam-Forming composition

Also Published As

Publication number Publication date
RU2561040C2 (ru) 2015-08-20
US9511019B2 (en) 2016-12-06
EP2470185B1 (en) 2016-11-16
US20120149667A1 (en) 2012-06-14
EP2470185A1 (en) 2012-07-04
AU2010288203B2 (en) 2014-09-25
JP2013503150A (ja) 2013-01-31
EP2298321A1 (en) 2011-03-23
CA2771871A1 (en) 2011-03-03
RU2012106898A (ru) 2013-10-10
AU2010288203A1 (en) 2012-03-15
CN102573852A (zh) 2012-07-11
JP5693581B2 (ja) 2015-04-01
CA2771871C (en) 2015-05-26
WO2011024122A1 (en) 2011-03-03

Similar Documents

Publication Publication Date Title
SMT201700008B (it) Composizione farmaceutica
BR112012004080A2 (pt) composições farmacêuticas para tratar ibd
SMT201600350B (it) Composizioni farmaceutiche
SMT201700095B (is) Composizioni farmaceutiche per inalazione
SMT201600307B (it) Composizione liposomiale
BRPI0918971A2 (pt) tienopirimidinas para composições farmacêuticas
DK3097925T3 (da) Farmaceutisk sammensætning
DK2694038T3 (da) Farmaceutisk sammensætning
BRPI1004940A2 (pt) composição farmacêutica
BR112014003052A2 (pt) composições farmacêuticas
DK3246018T3 (da) Farmaceutisk sammensætning
BR112012031667A2 (pt) composição
BRPI1013588A2 (pt) composição
BRPI1012539A2 (pt) composições farmacêuticas
BRPI1015939A2 (pt) composição farmacêutica
BR112012032683A2 (pt) composição
CO6930367A2 (es) Composiciones farmaceúticas
BRPI1015474A2 (pt) composição
EE201300005A (et) Ravimkoostis
IT1394400B1 (it) Composizioni farmaceutiche
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
BR112012032980A2 (pt) composição
CO6801722A2 (es) Composiciones farmacéuticas
BRPI1005318A2 (pt) composição
BR112012003149A2 (pt) composição farmacêutica

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2476 DE 19-06-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI